title: Dissociation of natural killer and lymphocyte-activated killer cell lytic activities in human CD3- large granular lymphocytes.
abstract: CD3- large granular lymphocytes (LGL) are known to display natural killer cell (NK) activity without prior sensitization or restriction by major histocompatibility antigens. Upon short-term exposure to interleukin-2, NK cells were shown to acquire lymphocyte-activated killer cell (LAK) activity. The aim of this study was to analyze the characteristics of these lytic activities. Our data indicated that both NK and LAK activities were Ca2+ dependent; however, they could be dissociated by a Ca2+ channel blocker or a Ca2+ channel competitor agent. Moreover, NK activity was associated with granule exocytosis of lytic proteins spontaneously present in CD3- LGL, the most likely candidate being the pore-forming protein perforin. By contrast, LAK activity was found to be dependent on de novo protein synthesis and distinct from granule exocytosis. Our results strongly suggest that NK and LAK activities could be defined as two distinct pathways involving different lytic mediators.
authors.affiliation: Hôpital Saint Louis INSERM U93, Paris, France.
authors.forename: M V
authors.initials: MV
authors.lastname: Clément
authors.forename: S
authors.initials: S
authors.lastname: Legros-Maida
authors.forename: A
authors.initials: A
authors.lastname: Soulie
authors.forename: J
authors.initials: J
authors.lastname: Guillet
authors.forename: M
authors.initials: M
authors.lastname: Sasportes
mesh_terms: D017252:CD3 Complex / Q000032:analysis; D002104:Cadmium / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D015550:Cell Degranulation; D002469:Cell Separation; D003513:Cycloheximide / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007113:Immunity, Innate; D066298:In Vitro Techniques; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology*; D016131:Lymphocyte Subsets / Q000276:immunology*; D008345:Manganese / Q000494:pharmacology
chemical_list: D017252:CD3 Complex; D002104:Cadmium; D008345:Manganese; D003513:Cycloheximide; D002118:Calcium